Katy Rezvani: Organizing Keystone Symposia Immune Cell Therapy

Katy Rezvani shared a post on X:

“Working with a great team including Nathan Singh and Stephan Mielke to organize Keystone Symposia Immune Cell Therapy: Advances in cancer and autoimmune disease.

Please join us to explore emerging research in Banff, March 16-19, 2025 at Fairmont Banff Springs, Banff, AB, Canada.

• Scholarship Deadline: December 9, 2024,
  
• Short Talk Abstract Deadline: December 9, 2024,
  
• Poster Abstract Deadline: February 20, 2025,
  
• Early Registration Deadline: January 28.”

Proceed further.

More posts featuring Katy Rezvani on oncodaily.com.

Katy Rezvani, is the Sally Cooper Murray Chair in Cancer Research at MD Anderson Cancer Center. Previously, she was Professor of Medicine and Chief of Section of Cellular Therapy at MD Anderson.

Dr. Rezvani’s research focuses on enhancing natural killer (NK) cell function against leukemia, utilizing genetic engineering techniques. Her work has led to funded Phase I/II trials in leukemia and lymphoma immunotherapy.